VentriPoint Diagnostics Competitors

Akumin (TSE:AKU) and VentriPoint Diagnostics (CVE:VPT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.

Valuation & Earnings

This table compares Akumin and VentriPoint Diagnostics' revenue, earnings per share (EPS) and valuation.

VentriPoint Diagnostics has lower revenue, but higher earnings than Akumin. VentriPoint Diagnostics is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Akumin and VentriPoint Diagnostics' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Akumin and VentriPoint Diagnostics, as provided by MarketBeat.

Akumin currently has a consensus target price of C$4.25, suggesting a potential upside of 10.39%. Given Akumin's higher possible upside, analysts clearly believe Akumin is more favorable than VentriPoint Diagnostics.

Summary

Akumin beats VentriPoint Diagnostics on 4 of the 7 factors compared between the two stocks.

VentriPoint Diagnostics (CVE:VPT) and LexaGene (CVE:LXG) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Profitability

This table compares VentriPoint Diagnostics and LexaGene's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares VentriPoint Diagnostics and LexaGene's gross revenue, earnings per share and valuation.

LexaGene has lower revenue, but higher earnings than VentriPoint Diagnostics. VentriPoint Diagnostics is trading at a lower price-to-earnings ratio than LexaGene, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and price targets for VentriPoint Diagnostics and LexaGene, as provided by MarketBeat.

Summary

VentriPoint Diagnostics beats LexaGene on 2 of the 3 factors compared between the two stocks.

SQI Diagnostics (CVE:SQD) and VentriPoint Diagnostics (CVE:VPT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for SQI Diagnostics and VentriPoint Diagnostics, as provided by MarketBeat.com.

Profitability

This table compares SQI Diagnostics and VentriPoint Diagnostics' net margins, return on equity and return on assets.

Earnings and Valuation

This table compares SQI Diagnostics and VentriPoint Diagnostics' gross revenue, earnings per share and valuation.

VentriPoint Diagnostics has lower revenue, but higher earnings than SQI Diagnostics. VentriPoint Diagnostics is trading at a lower price-to-earnings ratio than SQI Diagnostics, indicating that it is currently the more affordable of the two stocks.

Summary

VentriPoint Diagnostics beats SQI Diagnostics on 3 of the 5 factors compared between the two stocks.

VentriPoint Diagnostics (CVE:VPT) and Sernova (CVE:SVA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk.

Earnings and Valuation

This table compares VentriPoint Diagnostics and Sernova's revenue, earnings per share and valuation.

Sernova has lower revenue, but higher earnings than VentriPoint Diagnostics. Sernova is trading at a lower price-to-earnings ratio than VentriPoint Diagnostics, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and target prices for VentriPoint Diagnostics and Sernova, as reported by MarketBeat.com.

Profitability

This table compares VentriPoint Diagnostics and Sernova's net margins, return on equity and return on assets.

Summary

VentriPoint Diagnostics beats Sernova on 2 of the 3 factors compared between the two stocks.

GeneNews (TSE:GEN) and VentriPoint Diagnostics (CVE:VPT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.

Analyst Ratings

This is a breakdown of current recommendations and price targets for GeneNews and VentriPoint Diagnostics, as reported by MarketBeat.

Profitability

This table compares GeneNews and VentriPoint Diagnostics' net margins, return on equity and return on assets.

Valuation & Earnings

This table compares GeneNews and VentriPoint Diagnostics' revenue, earnings per share (EPS) and valuation.

VentriPoint Diagnostics has lower revenue, but higher earnings than GeneNews. VentriPoint Diagnostics is trading at a lower price-to-earnings ratio than GeneNews, indicating that it is currently the more affordable of the two stocks.

VentriPoint Diagnostics (CVE:VPT) and LED Medical Diagnostics (CVE:LMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Valuation and Earnings

This table compares VentriPoint Diagnostics and LED Medical Diagnostics' gross revenue, earnings per share (EPS) and valuation.

LED Medical Diagnostics has higher revenue and earnings than VentriPoint Diagnostics. VentriPoint Diagnostics is trading at a lower price-to-earnings ratio than LED Medical Diagnostics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares VentriPoint Diagnostics and LED Medical Diagnostics' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for VentriPoint Diagnostics and LED Medical Diagnostics, as reported by MarketBeat.com.

Summary

LED Medical Diagnostics beats VentriPoint Diagnostics on 3 of the 5 factors compared between the two stocks.